# OnKure Therapeutics, Inc.: Form 8-K, filed Feb 23, 2024

- Company: [OnKure Therapeutics, Inc.](/companies/okur.md) (CIK 1637715)
- Form: 8-K
- Filed: 2024-02-23
- Accepted by EDGAR: Feb 23, 2024, 21:00 ET
- Period: 2024-02-20
- Accession: 0000950170-24-019338
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1637715/000095017024019338/rphm-20240220.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1637715/000095017024019338/

## Items reported

- Item 2.05: Exit or disposal costs

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1637715/000095017024019338/rphm-20240220.htm

Filed Feb 23, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-019338. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.